Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR‐377‐3p/FGFR1/ERK axis
- 17 July 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 235 (2) , 1733-1745
Abstract
In the last decade, circular RNAs (circRNAs) emerge as important regulators in multiple biological processes. Lately, it is reported hsa_circRNA_103809 could play vital parts in several types of cancers. Based on the analysis of GEO data (GSE97332), hsa_circRNA_103809 was found to be dysregulated in hepatocellular carcinoma (HCC). However, the biological function and underlying regulatory mechanisms of hsa_circRNA_103809 in HCC remain unclear. Our results suggested that hsa_circRNA_103809 was overexpressed in HCC patients, and hsa_circRNA_103809 knockdown remarkably inhibited the proliferation, cycle progression, and migration of HCC cells. The investigations of molecular showed that hsa_circRNA_103809 could elevate the protein expression of a miR‐377‐3p target, fibroblast growth factor receptor 1 (FGFR1), through interacting with miR‐377‐3p and decreasing its expression level. Additionally, in vivo assays revealed hsa_circRNA_103809 short hairpin RNA served as a tumor suppressor through downregulating FGFR1 in HCC. This study systematically investigated novel regulatory signaling of hsa_circRNA_103809/miR‐377‐3p/FGFR1 axis, providing insights into hepatocellular carcinoma treatment from bench to clinic.Keywords
This publication has 34 references indexed in Scilit:
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasisBiochemical and Biophysical Research Communications, 2013
- Fibroblast growth factor receptors, developmental corruption and malignant diseaseCarcinogenesis, 2013
- Cancer stem cells in the development of liver cancerJournal of Clinical Investigation, 2013
- Mechanisms of FGFR-mediated carcinogenesisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular CarcinomaOncology, 2011
- Rapid in situ codetection of noncoding RNAs and proteins in cells and formalin-fixed paraffin-embedded tissue sections without protease treatmentNature Protocols, 2010
- MicroRNA Expression, Survival, and Response to Interferon in Liver CancerNew England Journal of Medicine, 2009
- The functions of animal microRNAsNature, 2004